tiprankstipranks
Argent BioPharma Grants Options to Executives
Company Announcements

Argent BioPharma Grants Options to Executives

Mgc Pharmaceuticals Ltd. (MGCLF) has released an update.

Pick the best stocks and maximize your portfolio:

Argent BioPharma Ltd has issued a total of 68,000 unlisted options to key management personnel as part of their managerial compensation. These options are exercisable at A$0.70 and must be used on or before April 1, 2029. The grants were made in accordance with the UK Market Abuse Regulations, and the transactions occurred outside of a trading venue on April 26, 2024.

For further insights into MGCLF stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks UK Auto-Generated NewsdeskArgent BioPharma to Delist from London Stock Exchange
TipRanks UK Auto-Generated NewsdeskArgent Biopharma Gains Strong Shareholder Support
TipRanks UK Auto-Generated NewsdeskArgent BioPharma’s Strategic Moves and Collaboration
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App